Latest Breaking News On - Biological products institute - Page 1 : comparemela.com

BEIJING (AP) A Chinese drugmaker said Wednesday its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries. The announcement by a unit of state-owned Sinopharm gave the first official data from a Chinese vaccine s late-stage trial. Its reported effectiveness rate is behind Pfizer Inc. s vaccine at 95% and Moderna Inc. s at 94%. Scientists have cautioned coronavirus vaccines may only be about as effective as flu vaccines, which generally are 50% effective. Sinopharm is one of at least five Chinese developers that are in a global race to create vaccines for the disease that has killed more than 1.7 million people. More than 1 million health care workers and others in China have received vaccines being developed by Sinopharm and another supplier, Sinovac, under emergency approval while testing was underway.

United statesT ai peiUnited arab emiratesTao linaJin dong yanChina national pharmaceutical groupUniversity of hong kongPfizer incWuhan institute of biological products ltdSinovac biotech ltdProducts institute ltdModerna incBeijing biological products institute ltdBeijing youth newsBeijing instituteWuhan institute